Clinical trials
Completed Phase 3 trials in Puerto Rico
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
925 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 13 |
| 2001 | 11 |
| 2002 | 20 |
| 2003 | 20 |
| 2004 | 29 |
| 2005 | 38 |
| 2006 | 47 |
| 2007 | 51 |
| 2008 | 53 |
| 2009 | 42 |
| 2010 | 47 |
| 2011 | 58 |
| 2012 | 53 |
| 2013 | 30 |
| 2014 | 43 |
| 2015 | 47 |
| 2016 | 38 |
| 2017 | 39 |
| 2018 | 34 |
| 2019 | 37 |
| 2020 | 28 |
| 2021 | 28 |
| 2022 | 25 |
| 2023 | 23 |
| 2024 | 12 |
| 2025 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 925 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Eli Lilly and Company | 118 |
| Novo Nordisk A/S | 54 |
| Gilead Sciences | 45 |
| Bristol-Myers Squibb | 43 |
| Children's Oncology Group | 42 |
| AstraZeneca | 38 |
| AbbVie | 36 |
| Hoffmann-La Roche | 32 |
| Novartis Pharmaceuticals | 32 |
| GlaxoSmithKline | 25 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Diabetes Mellitus, Type 2 | 134 |
| HIV Infections | 80 |
| Diabetes Mellitus | 60 |
| Acquired Immunodeficiency Syndrome | 42 |
| Hepatitis C | 39 |
| Arthritis, Rheumatoid | 32 |
| Breast Neoplasms | 23 |
| Obesity | 23 |
| Renal Insufficiency, Chronic | 22 |
| Hepatitis C, Chronic | 21 |
Trials
Showing 1 to 25 of 925. Each trial links to its page on Pharma Observatory.
825 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.